Viral infections during pregnancy are associated with significant adverse perinatal and fetal
outcomes. Pregnancy is a unique immunologic and physiologic state, which can influence …

Abstract Purpose of Review Selection of antiretroviral therapy during pregnancy must
consider maternal physiology and resulting pharmacokinetic changes in pregnancy …

Influenza A virus infection during pregnancy can cause adverse maternal and fetal
outcomes but the mechanism responsible remains elusive. Infection of outbred mice with …

Background We evaluated associations between antepartum weight change and adverse
pregnancy outcomes and between antiretroviral therapy (ART) regimens and week 50 …

The human immunodeficiency virus (HIV) was unknown until the early 1980's when
increasing numbers of cases of unusual opportunistic infections and Kaposi sarcoma in …

ABSTRACT Introduction The HIV/AIDS epidemic has been one of the greatest challenges in
global health, significantly affecting women of reproductive potential. Considerable …

Abstract Objectives Because NRTIs can have fetal toxicities, we evaluated a perinatal NRTI-
sparing strategy to prevent perinatal HIV transmission. Our primary objective was to …

Understanding early events during HIV infection and disease progression in CLWH serves
as a foundation for predicting or targeting later outcomes by harnessing the immune …

Introduction To prevent mother-to-child transmission (PMTCT) of the human
immunodeficiency virus (HIV) during pregnancy, the appropriate dosing regimens of …

Background Maternal HIV infection remains a significant global health concern with potential
repercussions on perinatal outcomes. Emphasis on early intervention to improve peri‐and …